Stop-smoking drug Champix ups risk of cardiovascular events for some people: study
by from on (#3B8QN)
The new year is a time when many smokers resolve to butt out for good. But a large Canadian study suggests a commonly prescribed tobacco-cessation drug may carry a risk for some people.